Rass Biosolution Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 30-06-2024
- Paid Up Capital ₹ 0.10 M
as on 30-06-2024
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -40.76%
(FY 2020)
- Profit 152.82%
(FY 2020)
- Ebitda 148.32%
(FY 2020)
- Net Worth 37.48%
(FY 2020)
- Total Assets 33.87%
(FY 2020)
About Rass Biosolution
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Satyam Khanna and Ram Khanna serve as directors at the Company.
- CIN/LLPIN
U73100UP2010PTC041140
- Company No.
041140
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jun 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Kanpur Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Rass Biosolution Private Limited offer?
Rass Biosolution Private Limited offers a wide range of products and services, including Vitamin Powder API, Ascorbic Acid Powder, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Pharma Ingredients & Raw Materials, Medical Laboratory Instruments, VTM Kit Raw Materials, Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Common Disease Medicines.
Who are the key members and board of directors at Rass Biosolution?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyam Khanna  | Director | 28-Jun-2010 | Current |
| Ram Khanna | Director | 24-Aug-2015 | Current |
Financial Performance and Corporate Structure Insights of Rass Biosolution.
Rass Biosolution Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 40.76% decrease. The company also saw a substantial improvement in profitability, with a 152.82% increase in profit. The company's net worth Soared by an impressive increase of 37.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rass Biosolution?
In 2018, Rass Biosolution had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rass Biosolution?
Unlock and access historical data on people associated with Rass Biosolution, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rass Biosolution, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rass Biosolution's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
